Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
QuantumPharm, Inc. ( (HK:2228) ) has provided an update.
XtalPi Holdings Limited has successfully completed the placement of 264 million new shares under a general mandate, generating approximately HK$1,125 million in net proceeds. This placement increases the company’s issued share capital by about 7.18% and involves investment from professional and institutional investors, potentially strengthening XtalPi’s market position and financial resources.
More about QuantumPharm, Inc.
XtalPi Holdings Limited, formerly known as QuantumPharm Inc., is a company incorporated in the Cayman Islands with limited liability. It operates within the pharmaceutical industry, focusing on innovative drug discovery and development, leveraging computational methods to enhance its research processes.
YTD Price Performance: -18.39%
Average Trading Volume: 88,507,579
Technical Sentiment Consensus Rating: Strong Buy
For detailed information about 2228 stock, go to TipRanks’ Stock Analysis page.